An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13063-020-04642-2
PubMed Identifier: 32807214
Publication URI: http://europepmc.org/abstract/MED/32807214
Type: Journal Article/Review
Volume: 21
Parent Publication: Trials
Issue: 1
ISSN: 1745-6215